Podcast Series Episode 5: Transforming the Visual Health of Young People in China

Zhaoke Ophthalmology Announces Full Results of Pivotal Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for the Treatment of Dry Eye Disease

Zhaoke Ophthalmology appoints PharmaLogic Development Inc. as Regulatory Consultant for Product Development in North America

First Patient Enrolled for the Investigator-Initiated trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Neurotrophic Keratitis

Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2020 China Top 100 Innovative Biotech Companies List”